HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY: ifrs:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss

Value{"amount": 168000000.0}
Period2024-01-01 – 2024-12-31
Statuscurrent
EntityHIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:549300BNS685UXH4JI75:2025-12-31
Retrieved: 2026-08-23T22:45:21.755947+02:00
Raw response sha256: c9b90e219264876c07ff9e67a0a5f951…
Cite as: FACTANKER, https://factanker.com/fact/4541427d-1fed-40a9-a88b-aa803dcb4382

History